Physician profile
Tracy D Burroughs
NPI 1104976760
$715.43
in general payments reported to CMS, 2019-2025
16 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $28.31 · 2021: $30.94 · 2022: $25.23 · 2023: $231 · 2024: $53.27 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $524.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $137.82 | 2023-2025 | Tyrvaya, Ryzumvi |
| Alcon Vision LLC | $108.18 | 2024-2025 | Rocklatan, Tryptyr |
| Tarsus Pharmaceuticals, INC. | $90.71 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $62.80 | 2023 | Vyzulta, Infuse, Miebo |
| Sun Pharmaceutical Industries INC. | $42.50 | 2025 | |
| Thea Pharma INC. | $40.35 | 2023 | Iyuzeh |
| Allergan, INC. | $39.80 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $32.55 | 2019 | |
| Glaukos Corporation | $28.31 | 2020 | |
| Coopervision INC. | $25.23 | 2022 | |
| Abbvie INC. | $22.07 | 2023 | Vuity, Lumigan, Alphagan P |
| Johnson & Johnson Vision Care, INC. | $19.80 | 2023 | Acuvue |
| Alcon Research LLC | $17.25 | 2019 | |
| Aerie Pharmaceuticals, INC. | $16.26 | 2019 | |
| Eyevance Pharmaceuticals LLC | $15.92 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $15.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Burroughs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.